MAPK3 and pancreatic neoplasm: This indicated that activation of B7-H3 by 4H7 induced variations in the levels of downstream molecules of ERK1/2, EGFR, and IκB, which might be associated with pancreatic cancer resistance to gemcitabine chemotherapy.